SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe Stephenson who wrote (81)2/16/1997 1:42:00 PM
From: Donald Gravenor   of 1321
 
I'll start with the 2nd question first---there was a wire story concerning Novartis' division CIBAvision, but I tossed it out, because there was apparently no confirmation.

Concerning the treatment of early stage lung cancer, they are probably referring to carcinoma in situ. Unfortunately, this is a non-dieease in N.A.; by the time there is an X-ray abnormality (basically the main technique to dx. lung CA) the cancer is already invasive.

Incidently, there was a nice one page article on QLT in the Feb. 15, 1997 Financial Post, which should be freely accessible by looking up canoe (iewww.canoe.com, or something like that).

Don Gravenor
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News